RANITIDINE

Manufacturer
WOCKHARDT LIMITED
Effective date
2011-11-21
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:30:12

Label at a glance#

ProductRANITIDINE
Active ingredientRANITIDINE HYDROCHLORIDE
Label structure14 sections

Indications and uses

relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages

Dosage and administration

adults and children 12 years and over: to relieve symptoms, swallow 1 tablet with a glass of water to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn can be used up to twice daily (do not take more than 2 tablets in 24 hours) children under 12 years: ask a doctor

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Ranitidine 75 mg (as ranitidine hydrochloride 84 mg)

Purpose

OTC - PURPOSE SECTION

Acid reducer

Uses

INDICATIONS & USAGE SECTION

  • relieves heartburn associated with acid indigestion and sour stomach
  • prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages

Warnings

WARNINGS SECTION

Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers

Do not use

OTC - DO NOT USE SECTION

  • if you have trouble or pain swallowing food, vomiting with blood, or bloody  or black stools. These may be signs of a serious condition. See your doctor.
  • with other acid reducers

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • frequent wheezing, particularly with heartburn       
  • frequent chest pain       
  • stomach pain
  • unexplained weight loss                                         
  • nausea or vomiting          
  • had heartburn over 3 months. This may be a sign of a more serious condition.
  • heartburn with lightheadedness, sweating or dizziness.
  • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • your heartburn continues or worsens
  • you need to take this product for more than 14 days

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • adults and children 12 years and over:
    • to relieve symptoms, swallow 1 tablet with a glass of water
    • to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn
    • can be used up to twice daily (do not take more than 2 tablets in 24 hours)
  • children under 12 years: ask a doctor

Other information

SPL UNCLASSIFIED SECTION

  • Blister:  Do not use if individual unit is open or torn 
    Bottle: do not use if printed foil under bottle cap is open or torn
  • store at 20°-25°C (68°-77°F)
  • avoid excessive heat or humidity
  • this product is sugar free

Inactive ingredients

INACTIVE INGREDIENT SECTION

colloidal silicon dioxide, croscarmellose sodium, diethyl phthalate, hypromellose, iron oxide red, magnesium stearate, microcrystalline cellulose and titanium dioxide.

OTC - QUESTIONS SECTION

Questions or Comments?
Call 1-800-346-6854

Read the directions, consumer information leaflet and warnings before use. Keep the carton. It contains important information.

Manufactured by:
Wockhardt Limited,
Mumbai, India.

Distributed by:
Wockhardt USA LLC.
20 Waterview Blvd.
Parsippany, NJ 07054
USA.

Iss.020410

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

500 T Label
500 T Label

500 T Carton
500 T Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
312773ranitidine 75 MG Oral TabletPSN1
312773ranitidine 75 MG Oral TabletSCD1
312773ranitidine 75 MG (as ranitidine hydrochloride 84 MG) Oral TabletSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
RANITIDINE Pharmacologic Class Indexing3Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
7f54af34-be54-4c3c-894f-78df6452d747Product name320190703
ccf8541e-b7dc-e6ba-06c9-15bf143a7850Product name520190611
05700d9e-ea6f-4aab-b0ed-1488f1d85d7bProduct name120180904
2f9d4e5c-e179-490e-8c43-f19e1e0ca228Product name120160720

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
55648-740-00RANITIDINE60000 in 1 DRUMTABLET, COATED600001
55648-740-01RANITIDINE10 in 1 BOTTLETABLET, COATED101
55648-740-01RANITIDINE1 in 1 CARTONTABLET, COATED11
55648-740-02RANITIDINE1 in 1 CARTONTABLET, COATED11
55648-740-02RANITIDINE100 in 1 BOTTLETABLET, COATED1001
55648-740-03RANITIDINE10 in 1 BLISTER PACKTABLET, COATED101
55648-740-03RANITIDINE10 in 1 CARTONTABLET, COATED101
55648-740-04RANITIDINE500 in 1 BOTTLETABLET, COATED5001
55648-740-04RANITIDINE1 in 1 CARTONTABLET, COATED11
55648-740-05RANITIDINE10000 in 1 POUCHTABLET, COATED100001

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
55648-740RANITIDINE TABLET, COATED [WOCKHARDT LIMITED]1Legacy NDC, 10 package rows20111122_ff374897-6078-4061-be9c-0b880595ab1f.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
RANITIDINE HYDROCHLORIDEACTIVE INGREDIENTBK76465IHM1
RANITIDINEACTIVE MOIETY884KT10YB71
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61U1
COLLOIDAL SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU41
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH481
DIETHYL PHTHALATEINACTIVE INGREDIENTUF064M00AF1
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G6751
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WO1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I301
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JP1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
55648-74055648-740-01, 55648-740-02, 55648-740-04, 55648-740-03, 55648-740-05, 55648-740-00

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 235 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UIMPLANT / INTRAVITREAL1.66 mgExact identifier — unii candidate
28 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / ORAL980 mgExact identifier — unii candidate
39 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPGEL / TOPICAL0.06 %w/wExact identifier — unii candidate
40 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4CREAM / VAGINAL51 mgExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30PELLET / ORAL24 mgExact identifier — unii candidate
39 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30RING / VAGINAL2 mgExact identifier — unii candidate
39 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30CAPSULE, DELAYED RELEASE / ORAL1060 mgExact identifier — unii candidate
39 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPOINTMENT / TOPICAL5 %w/wExact identifier — unii candidate
40 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / BUCCAL17.5 mgExact identifier — unii candidate
39 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOSUSPENSION/ DROPS / OPHTHALMIC3 mgExact identifier — unii candidate
27 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOTABLET, FILM COATED, EXTENDED RELEASE / ORAL221 mgExact identifier — unii candidate
27 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675CAPSULE, COATED PELLETS / ORAL2 mgExact identifier — unii candidate
21 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET / SUBLINGUAL10 mgExact identifier — unii candidate
49 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UPOWDER, FOR SOLUTION / ORAL690 mgExact identifier — unii candidate
28 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30POWDER, FOR SUSPENSION / ORAL120 mgExact identifier — unii candidate
39 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48GRANULE / ORAL150 mgExact identifier — unii candidate
22 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, COATED / ORAL49 mgExact identifier — unii candidate
40 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL0.15 mgExact identifier — unii candidate
21 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, EXTENDED RELEASE / ORAL90 mgExact identifier — unii candidate
40 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4CAPSULE, COATED / ORAL3 mgExact identifier — unii candidate
49 equally ranked IID candidates
DIETHYL PHTHALATEDIETHYL PHTHALATEUF064M00AFTABLET, FILM COATED / ORAL4 mgExact identifier — unii candidate
9 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPPASTE / DENTAL0.5 %w/wExact identifier — unii candidate
40 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675TABLET, FILM COATED, EXTENDED RELEASE / ORAL3.6 mgExact identifier — unii candidate
21 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOTABLET, DELAYED RELEASE / ORAL79 mgExact identifier — unii candidate
27 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675CAPSULE, COATED / ORAL0.12 mgExact identifier — unii candidate
21 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48TABLET, FOR SUSPENSION / ORAL1875 mgExact identifier — unii candidate
22 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPSUSPENSION / ORAL113 mgExact identifier — unii candidate
40 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675TABLET, DELAYED RELEASE / ORAL37 mgExact identifier — unii candidate
21 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675DROPS / ORALNAExact identifier — unii candidate
21 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48TABLET, COATED / ORAL224 mgExact identifier — unii candidate
22 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET, CHEWABLE / ORAL1725 mgExact identifier — unii candidate
28 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UPELLET / ORAL1140 mgExact identifier — unii candidate
28 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30CAPSULE, COATED, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
39 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48TABLET, ORALLY DISINTEGRATING / ORAL184 mgExact identifier — unii candidate
22 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48TABLET / ORAL736 mgExact identifier — unii candidate
22 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL69 mgExact identifier — unii candidate
49 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TAMPON / VAGINALNAExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, ORALLY DISINTEGRATING / ORAL187 mgExact identifier — unii candidate
39 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30WAFER / ORAL66 mgExact identifier — unii candidate
39 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL1576 mgExact identifier — unii candidate
28 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTROCHE / ORAL300 mgExact identifier — unii candidate
28 equally ranked IID candidates
DIETHYL PHTHALATEDIETHYL PHTHALATEUF064M00AFCAPSULE, DELAYED RELEASE / ORAL15 mgExact identifier — unii candidate
9 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48CAPSULE, EXTENDED RELEASE / ORAL53 mgExact identifier — unii candidate
22 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30SYSTEM / INTRAVITREAL0.02 mgExact identifier — unii candidate
39 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4FILM, SOLUBLE / ORAL2 mgExact identifier — unii candidate
49 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOLOTION / TOPICAL0.1 %w/wExact identifier — unii candidate
27 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPFILM, SOLUBLE / ORAL2 mgExact identifier — unii candidate
40 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET, EXTENDED RELEASE / ORAL5119 mgExact identifier — unii candidate
28 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30IMPLANT / SUBCUTANEOUS0.5 mgExact identifier — unii candidate
39 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOGRANULE / ORAL45 mgExact identifier — unii candidate
27 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TROCHE / ORAL315 mgExact identifier — unii candidate
39 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, FILM COATED / ORAL36 mgExact identifier — unii candidate
40 equally ranked IID candidates
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL42 mgExact identifier — unii candidate
40 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61USUSPENSION / ORAL1600 mgExact identifier — unii candidate
28 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30POWDER / RESPIRATORY (INHALATION)0.13 mgExact identifier — unii candidate
39 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675TABLET, COATED / ORAL1 mgExact identifier — unii candidate
21 equally ranked IID candidates
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOCAPSULE, COATED PELLETS / ORAL3.32 mgExact identifier — unii candidate
27 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675TABLET, CHEWABLE / ORAL2 mgExact identifier — unii candidate
21 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, FILM COATED, EXTENDED RELEASE / ORAL336 mgExact identifier — unii candidate
49 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, SUGAR COATED / ORALNAExact identifier — unii candidate
39 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A078884-001RANITIDINE HYDROCHLORIDERANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-31

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-10-15 13:18:302026-09A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-31c2088c7a36db…
2026-09-14 22:38:342026-08A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-3184e616aacf4f…
2026-08-18 06:07:402026-07A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-31caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-31011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-3131067a03dcf5…
2025-08-23 18:47 UTC2025-08A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-316a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-31fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-31b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-3103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-312680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-315bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-31d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-31d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-3179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-31301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-311e350fbaab3a…
2024-05-31 18:47 UTC2024-05A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-318072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-315c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-315d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-314b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-3174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-31bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-31782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-3187673890dc5c…
2021-03-12 10:30 UTC2021-03A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-315aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-318869cabd3fbd…
2020-11-12 02:37 UTC2020-11A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-31c0c555d07b60…
2019-12-14 00:12 UTC2019-12A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-313f01610625f2…
2019-09-15 20:21 UTC2019-09A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-31b00525d2431f…
2019-07-19 19:46 UTC2019-07A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-31ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-316a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-311c564ffb4f44…
2023-12-20 04:57 UTC2023-12A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-31ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-31a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-319b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-31a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-313f0d92c62455…
2023-05-13 08:27 UTC2023-05A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-31053a50430f4f…
2023-01-26 05:58 UTC2023-01A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-313bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A078884-001RANITIDINE HYDROCHLORIDEEQ 75MG BASETABLET / ORAL2008-07-313a93d1ddd44b…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
f60514be-7bf5-48bb-9a26-e1a70b7e74c1ff374897-6078-4061-be9c-0b880595ab1f2011-11-21WarningsExact identifier
spl id: f60514be-7bf5-48bb-9a26-e1a70b7e74c1
spl set id: ff374897-6078-4061-be9c-0b880595ab1f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.